ZIVO Bioscience, Inc. (ZIVO) Financials
ZIVO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 443476 | 3.8 million |
| March 31, 2026 | 516785 | 3.9 million |
| Dec. 31, 2025 | 663595 | 4.4 million |
| Sept. 30, 2025 | 559452 | 3.8 million |
ZIVO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -896310 | ? |
| March 31, 2026 | -210700 | ? |
| Dec. 31, 2025 | -1.1 million | ? |
| Sept. 30, 2025 | -266556 | 26959 |
ZIVO Net Income
No data available :(
ZIVO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 113795 | - | 18677 |
| March 31, 2026 | 4018 | - | 183533 |
| Dec. 31, 2025 | 67058 | - | 202241 |
| Sept. 30, 2025 | 57222 | 11663 | 285837 |
ZIVO Shares Outstanding
ZIVO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 3 | 37948 | 471040 | - |
| March 31, 2026 | 4 | 203626 | 739137 | - |
| Dec. 31, 2025 | 5 | 881457 | 2.1 million | - |
| Sept. 30, 2025 | - | 203444 | 836187 | - |
ZIVO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | 65625 | 44337 |
ZIVO
Price: $6.23
52 week price:
Earnings Per Share: -2.18 USD
P/E Ratio: -4.24
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1447
Market Capitalization: 15.6 million